{"id":2018,"date":"2009-07-17T14:44:55","date_gmt":"2009-07-17T13:44:55","guid":{"rendered":"https:\/\/drugprevent.org.uk\/ppp\/?p=2018"},"modified":"2009-07-17T14:44:55","modified_gmt":"2009-07-17T13:44:55","slug":"needle-exchange-and-risk-behaviours","status":"publish","type":"post","link":"https:\/\/drugprevent.org.uk\/ppp\/2009\/07\/needle-exchange-and-risk-behaviours\/","title":{"rendered":"Needle exchange and Risk Behaviours"},"content":{"rendered":"<p>Johns Hopkins University researchers describe recent findings. This trend article about Johns Hopkins University is an immediate alert from LawRx to identify developing directions of research.<\/p>\n<p>Study 1: Targeting HIV prevention interventions based upon risk group membership alone fails to address the distinct risk behaviors and demographic characteristics of enrollees in different programs.<\/p>\n<p>According to a recent study from the United States, &#8220;Injection drug use has accounted for more than one third of acquired immune deficiency syndrome cases in the United States. The purpose of this study was to compare the demographic characteristics, types, and frequency of human immunodeficiency virus (HIV)-risk behaviors among injection drug users (IDUs) recruited from a needle exchange program (NEP), methadone maintenance treatment (MMT), and detoxification (detox) program.&#8221;<\/p>\n<p>&#8220;A cross-sectional, correlational design was used to determine whether the selected HIV-risk behaviors and demographic characteristics of IDUs varied by site of recruitment. Confidential questionnaires were completed by 445 IDUs in Philadelphia, Pennsylvania,&#8221; explained H.D. Mark and colleagues at Johns Hopkins University.<\/p>\n<p>&#8220;Data analysis revealed that HIV sexual and injection-risk behavior varied by recruitment site. Subjects recruited from the NEP were more likely to engage in HIV-risk behaviors than subjects recruited from the MMT or detox sites,&#8221; reported investigators.<\/p>\n<p>They concluded, &#8220;Interventions occurring in program and treatment sites need to be sensitive to various demographic characteristics and behaviors if they are to reach those at highest risk of HIV infection. Targeting HIV prevention interventions based upon risk group membership alone (e.g, IDUs) fails to address the distinct risk behaviors and demographic characteristics of enrollees in different programs.&#8221;<\/p>\n<p>Mark and colleagues published their study in Public Health Nursing (Profiles of self-reported HIV-risk behaviors among injection drug users in methadone maintenance treatment, detoxification, and needle exchange programs. Public Health Nurs, 2006;23(1):11-19).<\/p>\n<div style=\"text-align: right;\"><span style=\"font-style: italic;\">Source: AIDS Weekly &amp; Law June 22, 2006 SECTION: EXPANDED REPORTING; Pg. 82 <\/span><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Johns Hopkins University researchers describe recent findings. This trend article about Johns Hopkins University is an immediate alert from LawRx to identify developing directions of research. Study 1: Targeting HIV prevention interventions based upon risk group membership alone fails to address the distinct risk behaviors and demographic characteristics of enrollees in different programs. According to [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[67],"tags":[],"class_list":["post-2018","post","type-post","status-publish","format-standard","hentry","category-needle-exchange"],"_links":{"self":[{"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/posts\/2018","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/comments?post=2018"}],"version-history":[{"count":0,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/posts\/2018\/revisions"}],"wp:attachment":[{"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/media?parent=2018"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/categories?post=2018"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/tags?post=2018"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}